Moderna's newly updated COVID-19 vaccine demonstrates promising efficacy against emerging variants, according to recent trial data. The updated shot is...
Biohaven, has unveiled optimistic data from its recent Phase 1 EEG biomarker study of BHV-7000, a novel epilepsy treatment. The...
In a pioneering study, Stanford Medicine researchers have identified predictable and sequential genetic changes that occur in cells leading to...
The University of Edinburgh's research suggests that the positioning of certain immune cells within lung tumours could predict patient survival and treatment response. This could enhance the...Read more
FDA has given Orphan Drug Designation to Faron Pharmaceuticals' bexmarilimab, a treatment designed for acute myeloid leukaemia. This breakthrough in drug designation is set to bring advantages...Read more
In an innovative study, researchers from Japan's RIKEN Center for Integrative Medical Sciences have identified specific gut bacteria that may play a pivotal role in battling insulin...Read more
A groundbreaking advance in the fight against the opioid epidemic is unfolding at the University of Montana. Vaccines targeting fatal opioids, fentanyl and heroin, are set to...Read more
In a groundbreaking study, Bayer's subsidiary, BlueRock Therapeutics, revealed positive early-stage results for its stem cell therapy aimed at treating Parkinson's disease. The trial, consisting of 12...Read more
A groundbreaking antibiotic discovery promises to give the world a new weapon against "superbugs". Researchers from the University of Bonn, have decoded the workings of a fresh...Read more
According to the phase 3 STEP HFpEF study published in The New England Journal of Medicine, the popular diabetes and weight loss drug Wegovy (semaglutide) significantly reduced...Read more
Recent research unveils ChatGPT's groundbreaking potential in the medical field. The AI chatbot demonstrates a notable 72% accuracy rate in clinical decisions. The study shows how ChatGPT...Read more
FDA has greenlit the first gene therapy, Elevidys, designed for pediatric patients with Duchenne muscular dystrophy (DMD) - a condition caused by a defective gene that leads...Read more